|
88
|
244
|
4zntA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a 3-bromo-substituted obhs derivative |
|
90
|
241
|
4zi1A |
Human estrogen receptor beta ligand-binding domain in complex with kb095285 and cia12 coactivator peptide |
|
90
|
250
|
4zn9A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with oxabicyclic heptene sulfonate (obhs) |
|
90
|
244
|
4zn7A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with diethylstilbestrol |
|
98
|
272
|
4yt1A |
Human ppar gamma ligand binding domain in complex with a gammma selective synthetic partial agonist mekt76 |
|
96
|
243
|
4ypqA |
Crystal structure of the ror(gamma)t ligand binding domain in complex with 4-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-1h-indazol-3-yl)benzoic acid |
|
99
|
259
|
4ymqA |
X-ray co-structure of nuclear receptor ror-gammat + src2 peptide with a benzothiadiazole dioxide inverse agonist |
|
80
|
231
|
4pojA |
Crystal structure of human retinoid x receptor alpha-ligand binding domain complex with 7-methyl uab30 and the coactivator peptide grip-1 |
|
98
|
271
|
4f9mA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
86
|
268
|
4e4kA |
Crystal structure of ppargamma with the ligand jo21 |
|
93
|
271
|
4emaA |
Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone |
|
97
|
268
|
4e4qA |
Crystal structure of ppargamma with the ligand fs214 |
|
100
|
271
|
4em9A |
Human ppar gamma in complex with nonanoic acids |
|
91
|
239
|
4dorA |
Human nuclear receptor liver receptor homologue-1, lrh-1, in its apo state bound to a fragment of human shp box1 |
|
94
|
242
|
4dosA |
Human nuclear receptor liver receptor homologue-1, lrh-1, bound to dlpc and a fragment of tif-2 |
|
92
|
234
|
4dqmA |
Revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique binding mode and antitumor activity |
|
93
|
240
|
4dm6A |
Crystal structure of rarb lbd homodimer in complex with ttnpb |
|
92
|
241
|
4dk8A |
Crystal structure of lxr ligand binding domain in complex with partial agonist 5 |
|
91
|
245
|
4dmaA |
Crystal structure of era lbd in complex with ru100132 |
|
101
|
247
|
4csjA |
The discovery of potent selective glucocorticoid receptor modulators, suitable for inhalation |
|
82
|
243
|
4dk7A |
Crystal structure of lxr ligand binding domain in complex with full agonist 1 |
|
81
|
240
|
4dm8A |
Crystal structure of rarb lbd in complex with 9cis retinoic acid |
|
97
|
264
|
4ci4A |
Structural basis for gl479 a dual peroxisome proliferator-activated receptor alpha agonist |
|
100
|
263
|
4bcrA |
Structure of pparalpha in complex with wy14643 |
|
52
|
202
|
4b7wA |
Ligand binding domain human hepatocyte nuclear factor 4alpha: apo form |
|
102
|
275
|
4a4vA |
Ligand binding domain of human ppar gamma in complex with amorfrutin 2 |
|
96
|
250
|
4apuA |
Pr x-ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids |
|
103
|
250
|
3zraA |
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators |
|
104
|
250
|
3zrbA |
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators |
|
106
|
250
|
3zr7A |
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators |
|
105
|
275
|
4a4wA |
Ligand binding domain of human ppar gamma in complex with amorfrutin b |
|
98
|
250
|
3zqtA |
Targeting the binding function 3 site of the androgen receptor through in silico molecular modeling |
|
96
|
250
|
4a2jA |
Pr x-ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids |
|
98
|
251
|
3wtqA |
Crystal structure of vdr-lbd complexed with 22s-butyl-2-methylidene-19-nor-1a,25-dihydroxyvitamin d3 |
|
101
|
272
|
3wj5A |
Crystal structure of ppargamma ligand binding domain in complex with triphenyltin |
|
93
|
270
|
3x1iA |
Hppargamma ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid |
|
98
|
251
|
3w5pA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
98
|
249
|
3wfgA |
Mineralocorticoid receptor ligand-binding domain with compuond 2e |
|
96
|
251
|
3wt7A |
Crystal structure of vdr-lbd complexed with 22r-butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1 ,25-dihydroxyvitamin d3 |
|
99
|
270
|
3wj4A |
Crystal structure of ppargamma ligand binding domain in complex with tributyltin |
|
100
|
251
|
3w5qA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
100
|
268
|
3x1hA |
Hppargamma ligand binding domain in complex with 5-oxo-tricosahexaenoic acid |
|
96
|
250
|
3wt6A |
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin d receptor: active vitamin d analogues with 22r-alkyl group |
|
98
|
272
|
3wmhA |
Human ppar gamma ligand binding domain in complex with a gammma selective synthetic partial agonist mekt75 |
|
100
|
251
|
3wt5A |
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin d receptor: active vitamin d analogues with 22r-alkyl group |
|
103
|
258
|
3wffA |
Mineralocorticoid receptor ligand-binding domain with compuond 2b |
|
99
|
253
|
3w0iA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
100
|
253
|
3w0gA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
99
|
253
|
3w5rA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
97
|
258
|
3w0hA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
